Is CBOP/BEP an alternative to BEP for patients with poor prognosis metastatic germ cell tumours?

ESMO Open. 2016 Aug 25;1(4):e000089. doi: 10.1136/esmoopen-2016-000089. eCollection 2016.

Authors

A Addeo¹, V Fusco², J P Braybrooke¹

Affiliations

¹ Bristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust , Bristol , UK.
² Oncology Unit , SS Antonio e Biagio e Cesare Arrigo Hospital , Alessandria , Italy.

No abstract available

Keywords: CBOP/BEP; Patients selection; germ cell tumor.

Publication types

Editorial